No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr22:27536600-27555000 |
Weak transcription |
Placenta Amnion |
Placenta Amnion
|
2 |
chr22:27545800-27546800 |
Enhancers |
A549 |
lung
|
3 |
chr22:27545800-27546800 |
Enhancers |
NH-A |
brain
|
4 |
chr22:27545800-27547200 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
5 |
chr22:27545800-27547200 |
Enhancers |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
6 |
chr22:27545800-27547400 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
7 |
chr22:27545800-27547400 |
Enhancers |
Brain Germinal Matrix |
brain
|
8 |
chr22:27545800-27547400 |
Enhancers |
Fetal Stomach |
stomach
|
9 |
chr22:27545800-27547800 |
Enhancers |
Fetal Brain Male |
brain
|
10 |
chr22:27545800-27548000 |
Enhancers |
Fetal Brain Female |
brain
|
11 |
chr22:27545800-27548200 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
12 |
chr22:27545800-27551200 |
Enhancers |
HUVEC |
blood vessel
|
13 |
chr22:27546000-27546800 |
Enhancers |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
14 |
chr22:27546000-27546800 |
Bivalent Enhancer |
Skeletal Muscle Male |
skeletal muscle
|
15 |
chr22:27546000-27546800 |
Enhancers |
HSMM |
muscle
|
16 |
chr22:27546000-27547000 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
17 |
chr22:27546000-27547000 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
18 |
chr22:27546000-27547000 |
Enhancers |
Lung |
lung
|
19 |
chr22:27546000-27547000 |
Enhancers |
Stomach Smooth Muscle |
stomach
|
20 |
chr22:27546000-27547000 |
Enhancers |
HSMMtube |
muscle
|
21 |
chr22:27546000-27547200 |
Enhancers |
Duodenum Smooth Muscle |
Duodenum
|
22 |
chr22:27546000-27547200 |
Enhancers |
Spleen |
Spleen
|
23 |
chr22:27546000-27547400 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
24 |
chr22:27546000-27547400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
25 |
chr22:27546000-27547400 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
26 |
chr22:27546000-27547400 |
Bivalent Enhancer |
Skeletal Muscle Female |
skeletal muscle
|
27 |
chr22:27546000-27547400 |
Enhancers |
NHLF |
lung
|
28 |
chr22:27546000-27547600 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
29 |
chr22:27546200-27546800 |
Bivalent Enhancer |
Fetal Lung |
lung
|
30 |
chr22:27546200-27547000 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
31 |
chr22:27546200-27547400 |
Bivalent Enhancer |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
32 |
chr22:27546200-27547400 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
33 |
chr22:27546400-27546800 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
34 |
chr22:27546400-27546800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
35 |
chr22:27546400-27546800 |
Flanking Active TSS |
Adipose Nuclei |
Adipose
|
36 |
chr22:27546400-27547000 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
37 |
chr22:27546400-27547000 |
Enhancers |
NHEK |
skin
|
38 |
chr22:27546400-27547600 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
39 |
chr22:27546600-27546800 |
Active TSS |
Duodenum Mucosa |
Duodenum
|
40 |
chr22:27546600-27546800 |
Bivalent Enhancer |
Fetal Kidney |
kidney
|
41 |
chr22:27546600-27546800 |
Bivalent Enhancer |
NHDF-Ad |
bronchial
|
42 |
chr22:27546600-27547000 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
43 |
chr22:27546600-27547000 |
Enhancers |
Osteobl |
bone
|
44 |
chr22:27546600-27547400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
45 |
chr22:27546600-27549400 |
Weak transcription |
Gastric |
stomach
|
46 |
chr22:27546600-27550800 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|